These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28628081)

  • 1. O-GlcNAcylation of fumarase maintains tumour growth under glucose deficiency.
    Wang T; Yu Q; Li J; Hu B; Zhao Q; Ma C; Huang W; Zhuo L; Fang H; Liao L; Eugene Chin Y; Jiang Y
    Nat Cell Biol; 2017 Jul; 19(7):833-843. PubMed ID: 28628081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK4 Phosphorylates Fumarase and Blocks TGFβ-Induced Cell Growth Arrest in Lung Cancer Cells.
    Chen T; Wang T; Liang W; Zhao Q; Yu Q; Ma CM; Zhuo L; Guo D; Zheng K; Zhou C; Wei S; Huang W; Jiang J; Liu J; Li S; He J; Jiang Y; Zhong N
    Cancer Res; 2019 Apr; 79(7):1383-1397. PubMed ID: 30683654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild Glucose Starvation Induces KDM2A-Mediated H3K36me2 Demethylation through AMPK To Reduce rRNA Transcription and Cell Proliferation.
    Tanaka Y; Yano H; Ogasawara S; Yoshioka S; Imamura H; Okamoto K; Tsuneoka M
    Mol Cell Biol; 2015 Dec; 35(24):4170-84. PubMed ID: 26416883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin activates KDM2A to reduce rRNA transcription and cell proliferation by dual regulation of AMPK activity and intracellular succinate level.
    Tanaka Y; Konishi A; Obinata H; Tsuneoka M
    Sci Rep; 2019 Dec; 9(1):18694. PubMed ID: 31822720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The decisive role of fumarase: Responsive signaling to glucose deficiency.
    Yu Q; Wang T; Jiang Y
    Mol Cell Oncol; 2018; 5(4):e1363848. PubMed ID: 30250906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells.
    Dhar SS; Alam H; Li N; Wagner KW; Chung J; Ahn YW; Lee MG
    J Biol Chem; 2014 Mar; 289(11):7483-96. PubMed ID: 24482232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CxxC-ZF domain is needed for KDM2A to demethylate histone in rDNA promoter in response to starvation.
    Tanaka Y; Umata T; Okamoto K; Obuse C; Tsuneoka M
    Cell Struct Funct; 2014; 39(1):79-92. PubMed ID: 24553073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-GlcNAcylation of TRIM29 and OGT translation forms a feedback loop to promote adaptive response of PDAC cells to glucose deficiency.
    Zhao FY; Chen X; Wang JM; Yuan Y; Li C; Sun J; Wang HQ
    Cell Oncol (Dordr); 2024 Jun; 47(3):1025-1041. PubMed ID: 38345749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
    Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
    Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
    Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of O-GlcNAcylation enhances exercise-dependent glucose utilization potentially through AMP-activated protein kinase activation in skeletal muscle.
    Murata K; Morino K; Ida S; Ohashi N; Lemecha M; Park SY; Ishikado A; Kume S; Choi CS; Sekine O; Ugi S; Maegawa H
    Biochem Biophys Res Commun; 2018 Jan; 495(2):2098-2104. PubMed ID: 29253568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy.
    Zhang X; Ma L; Qi J; Shan H; Yu W; Gu Y
    Mol Cell Biochem; 2015 Dec; 410(1-2):101-10. PubMed ID: 26318312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
    Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
    Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented O-GlcNAcylation of AMP-activated kinase promotes the proliferation of LoVo cells, a colon cancer cell line.
    Ishimura E; Nakagawa T; Moriwaki K; Hirano S; Matsumori Y; Asahi M
    Cancer Sci; 2017 Dec; 108(12):2373-2382. PubMed ID: 28973823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms.
    Fu LN; Wang YQ; Tan J; Xu J; Gao QY; Chen YX; Fang JY
    Oncogene; 2018 Jan; 37(3):389-402. PubMed ID: 28945223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
    Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
    BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
    Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
    Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.